Vaidya Sane Ayurved Laboratories Ratios

Vaidya Sane Ayurved Laboratories Ltd Ratios

The Vaidya Sane Ayurved Laboratories Ltd Ratios page provides a complete fundamental analysis of Vaidya Sane Ayurved Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Vaidya Sane Ayurved Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Vaidya Sane Ayurved Laboratories Ltd (NSE: MADHAVBAUG, BSE: 535434) is currently trading at ₹175, with a market capitalization of ₹1.84B. As a major player in the Health services sector and Medical/Nursing services industry, Vaidya Sane Ayurved Laboratories Ltd remains a key stock for fundamental analysis using Vaidya Sane Ayurved Laboratories Ltd Ratios.

Vaidya Sane Ayurved Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Vaidya Sane Ayurved Laboratories Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Vaidya Sane Ayurved Laboratories Ltd Ratios.

Historically, the Vaidya Sane Ayurved Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Vaidya Sane Ayurved Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Vaidya Sane Ayurved Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Vaidya Sane Ayurved Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Vaidya Sane Ayurved Laboratories Ltd P/S ratio currently stands at 0, an important part of Vaidya Sane Ayurved Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Vaidya Sane Ayurved Laboratories Ltd P/S ratio indicates cautious market sentiment.

Vaidya Sane Ayurved Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Vaidya Sane Ayurved Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Vaidya Sane Ayurved Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The declining Vaidya Sane Ayurved Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Vaidya Sane Ayurved Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Vaidya Sane Ayurved Laboratories Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Vaidya Sane Ayurved Laboratories Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Vaidya Sane Ayurved Laboratories Ltd EV/EBITDA ratio is currently 0, a key metric in Vaidya Sane Ayurved Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Vaidya Sane Ayurved Laboratories Ltd EV/EBITDA indicates balanced valuation.

Vaidya Sane Ayurved Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Vaidya Sane Ayurved Laboratories Ltd D/E ratio is currently 0.02, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.02
• 2023: 0.03
• 2022: 0
• 2021: 0.03

Vaidya Sane Ayurved Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Vaidya Sane Ayurved Laboratories Ltd ROE currently stands at 12.08%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 12.08
• 2023: 4.12
• 2022: 12.66
• 2021: 15.20

Vaidya Sane Ayurved Laboratories Ltd maintains stable profitability levels.

Vaidya Sane Ayurved Laboratories Ltd Ratios Analysis Summary

The Vaidya Sane Ayurved Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Vaidya Sane Ayurved Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Vaidya Sane Ayurved Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.